Master of Science Programs
Master of Science degree options
Johns Hopkins Carey Business School offers six Master of Science programs to equip students with specialized knowledge and skills in various disciplines. Taught by faculty who research for the future, our Master of Science programs are developed with data and are designed to respond to the changing business landscape. Four of the six full-time programs are STEM-designated, and all six full-time programs are offered on-site in Baltimore or Washington, D.C., or both. Five of the six MS programs offer a part-time option in a fully online, flexible format, allowing students to complete the program while continuing their personal and professional obligations.
Go beyond the classroom
Your business education doesn’t end in the classroom. Step out of your comfort zone as you partner with students across Johns Hopkins and businesses to put your classroom learning to the test.
Meet Greg Koory
Gregory Koory is an alumni of the Carey Business School’s MS in Real Estate and Infrastructure program. Before attending Carey, Greg graduated from the University of Michigan’s Law School with a J.D. and practiced law for 10 years. He graduated from the Carey Business School in 2015.
"In my class we have students with a variety of professional experience including accounting, government, finance, architecture and engineering. The students all bring their experience into the classroom, and it heightens the classroom discussion."
Greg Koory, MS in Real Estate and Infrastructure
Featured Business of Health stories
business of health
Q&A: Associate chief medical officer uses Carey MS in Health Care Management to lead through pandemic
business of health
Transforming public health with human-centered design
business of health
Generic vs. brand name and the cost of bad news
business of health
Q&A: Associate chief medical officer uses Carey MS in Health Care Management to lead through pandemic
business of health
Transforming public health with human-centered design
business of health
Generic vs. brand name and the cost of bad news